&nbsp;

Drugs Used:

lenalidomide,

dexamethasone

Quick Link(s):

Regimen Monograph

May 2022

Regimen

HYPERCVAD

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2022

Regimen

ENZL

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

Exceptional Access Program

enzalutamide - For the treatment of metastatic castrate-resistant prostate cancer (mCRPC), with specific clinical criteria

Exceptional Access Program

enzalutamide - For the treatment of high risk non-metastatic castration-resistant prostate cancer (nmCRPC), with specific clinical criteria

Exceptional Access Program

enzalutamide - For the treatment metastatic castration sensitive prostate cancer (mCSPC), with specific clinical criteria

Drugs Used:

enzalutamide

Quick Link(s):

Regimen Monograph

Apr 2022

Regimen

DOCE+PERT+TRAS

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

PACL+PERT+TRAS

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

PACL(W)+TRAS

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

PACLitaxel,

trastuzumab

Quick Link(s):

Regimen Monograph

Feb 2022

Regimen

TMXF

Cancer Type:

Gynecologic,

Endometrial,

Ovary

Intent: Palliative

Funding:

ODB - General Benefit

tamoxifen

Drugs Used:

tamoxifen

Quick Link(s):

Regimen Monograph

May 2022

Regimen

PACL(W)+PERT+TRAS

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

New Drug Funding Program

Pertuzumab with Trastuzumab (Biosimilar) - Unresectable Locally Recurrent or Metastatic Breast Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Sep 2022

Regimen

ERLO

Cancer Type:

Head and Neck

Intent: Palliative

Drugs Used:

erlotinib (Unfunded)

Quick Link(s):

Regimen Monograph

Oct 2022

Regimen

LENA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the maintenance treatment of patients with newly diagnosed multiple myeloma, following ASCT, according to clinical criteria

Drugs Used:

lenalidomide